Sandu Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 16.72 | 14.14 | 18.40 |
| Operating Expense | 16.17 | 13.62 | 17.38 |
| Net Profit | 0.22 | 0.33 | 0.56 |
| Net Profit Margin | 1.32 | 2.33 | 3.04 |
| Earning Per Share | 0.23 | 0.34 | 0.57 |
| EBIDTA | 0.53 | 0.58 | 1.01 |
| Effective Tax Rate | 18.52 | 13.46 | 22.55 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 16.72 |
| Operating Expense | 16.17 |
| Net Profit | 0.22 |
| Net Profit Margin | 1.32 |
| Earning Per Share | 0.23 |
| EBIDTA | 0.53 |
| Effective Tax Rate | 18.52 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 67.19 | 67.28 | 65.35 |
| Operating Expenses Annual | 64.43 | 64.98 | 62.86 |
| Operating Profit Annual | 2.93 | 2.72 | 2.82 |
| Interest Annual | 0.10 | 0.06 | 0.08 |
| Depreciation | 0.67 | 0.58 | 0.52 |
| Net Profit Annual | 1.55 | 1.46 | 1.52 |
| Tax Annual | 0.61 | 0.61 | 0.70 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 67.19 |
| Operating Expenses Annual | 64.43 |
| Operating Profit Annual | 2.93 |
| Interest Annual | 0.10 |
| Depreciation | 0.67 |
| Net Profit Annual | 1.55 |
| Tax Annual | 0.61 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 1 | 2.27 | 0.94 |
| Cash Flow from Operations | 0.95 | 0.76 | 0.22 |
| Cash Flow from Investing | -0.18 | -1.31 | 0.53 |
| Cash Flow from Financing | -0.46 | -0.72 | 0.58 |
| Cash Flow at the End | 1.30 | 1 | 2.27 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 1 |
| Cash Flow from Operations | 0.95 |
| Cash Flow from Investing | -0.18 |
| Cash Flow from Financing | -0.46 |
| Cash Flow at the End | 1.30 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 4.36 | 4.04 | 4.32 |
| PBIT Margin (%) | 3.36 | 3.18 | 3.52 |
| PBT Margin (%) | -30.28 | -49.58 | -40.47 |
| Net PROFIT Margin (%) | 2.31 | 2.17 | 2.33 |
| Return On Networth / Equity (%) | 4.74 | 4.11 | 4.56 |
| Return On Networth /Employed (%) | 6.87 | 5.98 | 6.89 |
| Return On Assets (%) | 3.74 | 3.65 | 4.02 |
| Total Debt / Equity (X) | TBA | TBA | TBA |
| Asset Turnover Ratio (%) | 1.62 | 1.68 | 1.73 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 4.36 |
| PBIT Margin (%) | 3.36 |
| PBT Margin (%) | -30.28 |
| Net PROFIT Margin (%) | 2.31 |
| Return On Networth / Equity (%) | 4.74 |
| Return On Networth /Employed (%) | 6.87 |
| Return On Assets (%) | 3.74 |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | 1.62 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 18.15 | 17.88 | 16.62 |
| Total Current Assets Annual | 26.30 | 22.30 | 25.54 |
| Non Current Assets Annual | 29.42 | 30.12 | 28.63 |
| Total Shareholders Funds Annual | 42.02 | 40.60 | 39.24 |
| Total Assets Annual | 55.72 | 52.42 | 54.17 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 18.15 |
| Total Current Assets Annual | 26.30 |
| Non Current Assets Annual | 29.42 |
| Total Shareholders Funds Annual | 42.02 |
| Total Assets Annual | 55.72 |
EPS (INR)
Expected
0.34
Reported
0.34
Surprise
0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by -1.72%
Jun 2024
EPS beaten by 275.00%
